Issue: FDA and Drug Regulation
     
 
En Español

The Power of Independent Thinking

←  ISSUES
Issues
›
Regulation
›
FDA and Drug Regulation
›
Commentary

Showing 71 - 80 of 204 Results.

Price Controls on Drugs Would Save Lives, but Also Take Them
Ronald L. Trowbridge | Commentary | Dec. 10, 2021
The FDA is Back and Coming after Smart Socks
Raymond J. March | Commentary | Nov. 11, 2021
Gain of Function Controversy Demands Greater Scrutiny for Government-Funded Science
Raymond J. March | Commentary | Nov. 3, 2021
Lessons from Employer Vaccination Mandates
William J. Watkins, Jr. | Commentary | Oct. 5, 2021
Fumento Misdiagnoses Remdesivir
Raymond J. March | Commentary | Oct. 4, 2021
The Politics of Health
John C. Goodman | Commentary | Sep. 14, 2021
Sorry Facebook, Forced Universal Vaccinations Are Not the Answer
All the Science Should Be Considered, Not Censored
Peter K. Navarro, Robert W. Malone, M.D., M.S. | Commentary | Sep. 3, 2021
Vaccine Inventor Questions Mandatory Shot Push, Biden’s Covid-19 Strategy
Vaccination “arms race” could prove dangerous to the American public
Robert W. Malone, M.D., M.S., Peter K. Navarro | Commentary | Aug. 23, 2021
Why Aren’t More Americans Getting Vaccinated?—Blame the FDA
Raymond J. March | Commentary | Aug. 11, 2021
Panic Won’t Stop the Delta Variant. The Market Will.
Raymond J. March | Commentary | July 21, 2021






  • Catalyst
  • Beyond Homeless
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org
© 2024 INDEPENDENT INSTITUTE, 100 SWAN WAY, OAKLAND CA 94621‑1428 | (510) 632‑1366 | (510) 568‑6040 FAX | SEND EMAIL